Literature DB >> 2669511

Hepatic glycogen in humans. I. Direct formation after oral and intravenous glucose or after a 24-h fast.

J Radziuk1.   

Abstract

The formation of hepatic glycogen by the direct pathway is assessed in humans 1) after a 12-h fast and oral loading (100 g) or 2) intravenous infusion (90 g) and 3) after a 24-h fast and the same oral glucose load. The methodology used is based on the double tracer method. [3-3H]glucose is infused at a constant rate for the determination of the metabolic clearance of glucose. [1-14C]glucose is administered with the glucose load. One hour after absorption or the intravenous glucose infusion is terminated, a glucagon infusion is initiated to mobilize the glycogen labeled with [1-14C]glucose and formed during the absorptive period. At this time a third tracer, [6-3H]glucose, is administered to measure glucose clearance. It was found that after the 12-h fast and oral glucose loading 7.2 +/- 1.1 g of hepatic glycogen appears to be formed directly from glucose compared with 8.4 +/- 1.0 g after the same load and a 24-h fast and 8.5 +/- 0.4 g after a 12-h fast and an equivalent intravenous glucose infusion. When the amount of label ([14C]glucose) mobilized that was not corrected for metabolic recycling was calculated, the data suggested that the amount of glycogen formed by gluconeogenic pathways was probably at least equal to that formed by direct uptake. It was also approximately 60% greater after a 24-h fast. It can be concluded that the amount of hepatic glycogen formed directly from glucose during glucose loading is not significantly altered by the route of entry or the extension of the fasting period to 24 h. The data suggest, however, that gluconeogenetic formation of glycogen increases with fasting.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2669511     DOI: 10.1152/ajpendo.1989.257.2.E145

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

1.  Use of a new gas chromatograph isotope ratio mass spectrometer to trace exogenous 13C labelled glucose at a very low level of enrichment in man.

Authors:  S Tissot; S Normand; R Guilluy; C Pachiaudi; M Beylot; M Laville; R Cohen; R Mornex; J P Riou
Journal:  Diabetologia       Date:  1990-08       Impact factor: 10.122

2.  Paradigm Shifts in Nocturnal Glucose Control in Type 2 Diabetes.

Authors:  Ananda Basu; Nisha Joshi; John Miles; Rickey E Carter; Robert A Rizza; Rita Basu
Journal:  J Clin Endocrinol Metab       Date:  2018-10-01       Impact factor: 5.958

3.  Changes in hepatic glycogen cycling during a glucose load in healthy humans.

Authors:  H Stingl; V Chandramouli; W C Schumann; A Brehm; P Nowotny; W Waldhäusl; B R Landau; M Roden
Journal:  Diabetologia       Date:  2005-12-28       Impact factor: 10.122

4.  Activation of basal gluconeogenesis by coactivator p300 maintains hepatic glycogen storage.

Authors:  Ling He; Jia Cao; Shumei Meng; Anlin Ma; Sally Radovick; Fredric E Wondisford
Journal:  Mol Endocrinol       Date:  2013-06-14

5.  Predominant role of gluconeogenesis in the hepatic glycogen repletion of diabetic rats.

Authors:  A Giaccari; L Rossetti
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

6.  Glycogen: its mode of formation and contribution to hepatic glucose output in postabsorptive humans.

Authors:  W Pimenta; N Nurjhan; P A Jansson; M Stumvoll; J Gerich; M Korytkowski
Journal:  Diabetologia       Date:  1994-07       Impact factor: 10.122

Review 7.  Tracking the carbons supplying gluconeogenesis.

Authors:  Ankit M Shah; Fredric E Wondisford
Journal:  J Biol Chem       Date:  2020-08-13       Impact factor: 5.157

8.  Effects of lactate on pathways of glycogen formation in the perfused rat liver.

Authors:  Z Zhang; J Radziuk
Journal:  Biochem J       Date:  1991-12-01       Impact factor: 3.857

9.  Restoration of hepatic glucokinase expression corrects hepatic glucose flux and normalizes plasma glucose in zucker diabetic fatty rats.

Authors:  Tracy P Torres; Reetta L Catlin; Robert Chan; Yuka Fujimoto; Noriyasu Sasaki; Richard L Printz; Christopher B Newgard; Masakazu Shiota
Journal:  Diabetes       Date:  2008-10-24       Impact factor: 9.461

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.